TrialTrials2014

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.

Khai P Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.